Plus disease in retinopathy of prematurity: More than meets the ICROP?

Layla Ghergherehchi, Sang Jin Kim, John Campbell, Susan Ostmo, R. V.Paul Chan, Michael Chiang

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Retinopathy of prematurity (ROP), a vasoproliferative retinal disease affecting premature infants, is a leading cause of childhood blindness throughout the world. Plus disease, defined as venous dilatation and arteriolar tortuosity within the posterior retinal vessels greater than or equal to that of a standard published photograph, is the most critical finding in identifying treatment-requiring ROP. Despite an internationally accepted definition of plus disease, there is significant variability in diagnostic process and outcome, producing variable levels of reported intra- and interexpert agreement. Several potential explanations for poor agreement have been proposed, including attention to undefined vascular features such as venous tortuosity, focus on narrower or wider field of view, unfamiliarity with digital images, the magnification and apparent severity of the standard photograph, and cut-off point differences among experts as to the level of tortuosity and dilation sufficient for "plus disease" along a continuum. Moreover, differences in diagnostic consistency among groups of experts separated both geographically and chronologically have been reported. These findings have implications for clinical care, research, and education, and highlight the need for a more precise definition of plus disease and objective diagnostic methods for ROP.

Original languageEnglish (US)
Pages (from-to)152-155
Number of pages4
JournalAsia-Pacific Journal of Ophthalmology
Volume7
Issue number3
DOIs
StatePublished - May 1 2018

Fingerprint

Retinopathy of Prematurity
Dilatation
Retinal Diseases
Retinal Vessels
Blindness
Premature Infants
Blood Vessels
Education
Research
Therapeutics

Keywords

  • Artificial intelligence
  • Deep learning
  • Diagnostic imaging
  • Plus disease
  • Retina
  • Retinopathy of prematurity

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Plus disease in retinopathy of prematurity : More than meets the ICROP? / Ghergherehchi, Layla; Kim, Sang Jin; Campbell, John; Ostmo, Susan; Chan, R. V.Paul; Chiang, Michael.

In: Asia-Pacific Journal of Ophthalmology, Vol. 7, No. 3, 01.05.2018, p. 152-155.

Research output: Contribution to journalReview article

Ghergherehchi, Layla ; Kim, Sang Jin ; Campbell, John ; Ostmo, Susan ; Chan, R. V.Paul ; Chiang, Michael. / Plus disease in retinopathy of prematurity : More than meets the ICROP?. In: Asia-Pacific Journal of Ophthalmology. 2018 ; Vol. 7, No. 3. pp. 152-155.
@article{d636489718f541f79806f57f1e7cbd47,
title = "Plus disease in retinopathy of prematurity: More than meets the ICROP?",
abstract = "Retinopathy of prematurity (ROP), a vasoproliferative retinal disease affecting premature infants, is a leading cause of childhood blindness throughout the world. Plus disease, defined as venous dilatation and arteriolar tortuosity within the posterior retinal vessels greater than or equal to that of a standard published photograph, is the most critical finding in identifying treatment-requiring ROP. Despite an internationally accepted definition of plus disease, there is significant variability in diagnostic process and outcome, producing variable levels of reported intra- and interexpert agreement. Several potential explanations for poor agreement have been proposed, including attention to undefined vascular features such as venous tortuosity, focus on narrower or wider field of view, unfamiliarity with digital images, the magnification and apparent severity of the standard photograph, and cut-off point differences among experts as to the level of tortuosity and dilation sufficient for {"}plus disease{"} along a continuum. Moreover, differences in diagnostic consistency among groups of experts separated both geographically and chronologically have been reported. These findings have implications for clinical care, research, and education, and highlight the need for a more precise definition of plus disease and objective diagnostic methods for ROP.",
keywords = "Artificial intelligence, Deep learning, Diagnostic imaging, Plus disease, Retina, Retinopathy of prematurity",
author = "Layla Ghergherehchi and Kim, {Sang Jin} and John Campbell and Susan Ostmo and Chan, {R. V.Paul} and Michael Chiang",
year = "2018",
month = "5",
day = "1",
doi = "10.22608/APO.201863",
language = "English (US)",
volume = "7",
pages = "152--155",
journal = "Asia-Pacific Journal of Ophthalmology",
issn = "2162-0989",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Plus disease in retinopathy of prematurity

T2 - More than meets the ICROP?

AU - Ghergherehchi, Layla

AU - Kim, Sang Jin

AU - Campbell, John

AU - Ostmo, Susan

AU - Chan, R. V.Paul

AU - Chiang, Michael

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Retinopathy of prematurity (ROP), a vasoproliferative retinal disease affecting premature infants, is a leading cause of childhood blindness throughout the world. Plus disease, defined as venous dilatation and arteriolar tortuosity within the posterior retinal vessels greater than or equal to that of a standard published photograph, is the most critical finding in identifying treatment-requiring ROP. Despite an internationally accepted definition of plus disease, there is significant variability in diagnostic process and outcome, producing variable levels of reported intra- and interexpert agreement. Several potential explanations for poor agreement have been proposed, including attention to undefined vascular features such as venous tortuosity, focus on narrower or wider field of view, unfamiliarity with digital images, the magnification and apparent severity of the standard photograph, and cut-off point differences among experts as to the level of tortuosity and dilation sufficient for "plus disease" along a continuum. Moreover, differences in diagnostic consistency among groups of experts separated both geographically and chronologically have been reported. These findings have implications for clinical care, research, and education, and highlight the need for a more precise definition of plus disease and objective diagnostic methods for ROP.

AB - Retinopathy of prematurity (ROP), a vasoproliferative retinal disease affecting premature infants, is a leading cause of childhood blindness throughout the world. Plus disease, defined as venous dilatation and arteriolar tortuosity within the posterior retinal vessels greater than or equal to that of a standard published photograph, is the most critical finding in identifying treatment-requiring ROP. Despite an internationally accepted definition of plus disease, there is significant variability in diagnostic process and outcome, producing variable levels of reported intra- and interexpert agreement. Several potential explanations for poor agreement have been proposed, including attention to undefined vascular features such as venous tortuosity, focus on narrower or wider field of view, unfamiliarity with digital images, the magnification and apparent severity of the standard photograph, and cut-off point differences among experts as to the level of tortuosity and dilation sufficient for "plus disease" along a continuum. Moreover, differences in diagnostic consistency among groups of experts separated both geographically and chronologically have been reported. These findings have implications for clinical care, research, and education, and highlight the need for a more precise definition of plus disease and objective diagnostic methods for ROP.

KW - Artificial intelligence

KW - Deep learning

KW - Diagnostic imaging

KW - Plus disease

KW - Retina

KW - Retinopathy of prematurity

UR - http://www.scopus.com/inward/record.url?scp=85049211224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049211224&partnerID=8YFLogxK

U2 - 10.22608/APO.201863

DO - 10.22608/APO.201863

M3 - Review article

C2 - 29797825

AN - SCOPUS:85049211224

VL - 7

SP - 152

EP - 155

JO - Asia-Pacific Journal of Ophthalmology

JF - Asia-Pacific Journal of Ophthalmology

SN - 2162-0989

IS - 3

ER -